ArticleFrontiers in immunology2025

IL-6 is a prognostic biomarker in patients with advanced esophageal squamous cell carcinoma received with PD-1 inhibitors.

Ping Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.